GTP Bioways is excited to announce our participation in the 14th edition of World ADC in London from March 12-15!

This event presents a unique opportunity for you to stay informed about the latest advancements in antibody-drug-conjugates (ADCs) development. ADCs have gained significant importance, generating heightened interest and investment in the field.

The event will cover the entire spectrum of ADC development and manufacturing, featuring sessions dedicated to next-generation ADCs (new payloads with new mechanisms of action, new linker-payload combinations as well as non-traditional antibody-drug conjugates) manufacturing processes. Key players from the pharmaceutical, biotech, and academic sectors will be present.

It is the perfect occasion to connect with GTP Bioways CDMO and discover our unique capabilities in terms of Valérie Girard, Downstream Process Manager, and Fanny Goy, Business Development Manager at GTP Biologics, will be happy to welcome you at booth #45. Do not miss the opportunity to exchange ideas, gather insights, and explore potential partnerships.

Discover our client centric CDMO and let GTP Bioways bring your project into clinical development

World ADC is the perfect occasion to discuss your needs in ADC development and gain valuable insights into our comprehensive range of services, including cell line development, mammalian and microbial GMP manufacturing, process development, and aseptic fill and finish.

We look forward to meeting you in London!